Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Error on the assay for cell-chex control lot 4244. mononuclear and olymorphonuclear percentages in the white blood count differential section are inverted for l1-uc l1-cc and l2. correct mononuclear value for all levels should be 26% and correct polymorphononuclear value for all levels should be 74%.